Pimonidazole

Catalog No.S9919 Batch:S991901

Print

Technical Data

Formula

C11H18N4O3

Molecular Weight 254.29 CAS No. 70132-50-2
Solubility (25°C)* In vitro DMSO 51 mg/mL (200.55 mM)
Ethanol 51 mg/mL (200.55 mM)
Water Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description Pimonidazole (Ro 03-8799) is a novel hypoxia marker used for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma.
In vitro

Pimonidazole has radio-sensitivity and recovery capacity from radiation-induced damage depend on p53 status of the tumor cell.<sup><a class="sref" href="#s_ref">[3]</a></sup>

In vivo

Pimonidazole can overcome radiation resistance in hypoxiaby melanoma cells, which is enhanced by liposome modification.<sup><a class="sref" href="#s_ref">[2]</a></sup>

Protocol (from reference)

Cell Assay:

<sup><a class="sref" href="#s_ref">[3]</a></sup>

  • Cell lines

    HMV-II human malignant melanoma cells

  • Concentrations

    0.5 mM

  • Incubation Time

    1–4 h

  • Method

    HMV-II cells are seeded by 2,000 cells per well in 96-well culture plates, allowed to adhere for 30 hr in a humidified atmosphere with 5% CO<sub>2</sub> at 37 C, and followed by incubation in a hypoxic condition of 100% N2 set in a glass desicator for 18 hr. The liposomal Pmz or free-Pmz is applied in 100 μL of degassed medium and incubated for 3 hr in a hypoxic condition of 100% N2 set in a glass desicator. After X-ray irradiation, the cells are incubated for 3 hr in a humidified atmosphere with 5% CO2 at 37 C.  The cells are confirmed to survive according to either morphological observation or cell viability assay using the redox indicator WST-8.

Animal Study:

<sup><a class="sref" href="#s_ref">[2]</a></sup>

  • Animal Models

    Human head and neck cancer xenograft model mice (BALB/c athymic nude mice; inoculated with FaDu cells)

  • Dosages

    200 mg/kg

  • Administration

    IOCV

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.